Dr. Aseem Malhotra

Now, interestingly, and of course, one of the most extraordinary bits in the actual newspaper, the editorial from the health editor headline was, there is a special place in hell for doctors who say statins don't work. Hmm. Okay. And then imagine a picture of me, Zoe Arkham, and Harkam, right?

Now, interestingly, and of course, one of the most extraordinary bits in the actual newspaper, the editorial from the health editor headline was, there is a special place in hell for doctors who say statins don't work. Hmm. Okay. And then imagine a picture of me, Zoe Arkham, and Harkam, right?

Now, interestingly, and of course, one of the most extraordinary bits in the actual newspaper, the editorial from the health editor headline was, there is a special place in hell for doctors who say statins don't work. Hmm. Okay. And then imagine a picture of me, Zoe Arkham, and Harkam, right?

Exactly, right? I mean, I find it funny, to be honest. I mean, of course, a lot of other people were more upset than I was. In fact, the former Queen of England's doctor and the past president of the Royal College of Physicians, Sir Richard Thompson, who I'm friends with, I mean, he called me up and he was so upset. He's like, this is unbelievable.

Exactly, right? I mean, I find it funny, to be honest. I mean, of course, a lot of other people were more upset than I was. In fact, the former Queen of England's doctor and the past president of the Royal College of Physicians, Sir Richard Thompson, who I'm friends with, I mean, he called me up and he was so upset. He's like, this is unbelievable.

Exactly, right? I mean, I find it funny, to be honest. I mean, of course, a lot of other people were more upset than I was. In fact, the former Queen of England's doctor and the past president of the Royal College of Physicians, Sir Richard Thompson, who I'm friends with, I mean, he called me up and he was so upset. He's like, this is unbelievable.

How can they say, this is not what you say, blah, blah, blah.

How can they say, this is not what you say, blah, blah, blah.

How can they say, this is not what you say, blah, blah, blah.

And I was calming him down and saying, Richard, we take this as a backhanded compliment. You're over the target. You get one of the most powerful, influential newspapers in the world to go for you like this. And I'm someone that- Well, that's a fair point.

And I was calming him down and saying, Richard, we take this as a backhanded compliment. You're over the target. You get one of the most powerful, influential newspapers in the world to go for you like this. And I'm someone that- Well, that's a fair point.

And I was calming him down and saying, Richard, we take this as a backhanded compliment. You're over the target. You get one of the most powerful, influential newspapers in the world to go for you like this. And I'm someone that- Well, that's a fair point.

But I think ultimately what came out in the case as well, Mark, and there's also, again, I'll mention this crucial bit of evidence, which is extraordinary and helped, I think, shift the case and win it, is that the people who were fueling the health editor to write the article and the people who are commenting on it were all connected or part of something called the CTT, the Cholesterol Trialist Collaboration in Oxford.

But I think ultimately what came out in the case as well, Mark, and there's also, again, I'll mention this crucial bit of evidence, which is extraordinary and helped, I think, shift the case and win it, is that the people who were fueling the health editor to write the article and the people who are commenting on it were all connected or part of something called the CTT, the Cholesterol Trialist Collaboration in Oxford.

But I think ultimately what came out in the case as well, Mark, and there's also, again, I'll mention this crucial bit of evidence, which is extraordinary and helped, I think, shift the case and win it, is that the people who were fueling the health editor to write the article and the people who are commenting on it were all connected or part of something called the CTT, the Cholesterol Trialist Collaboration in Oxford.

These are the most powerful statin promoters and some of the most powerful doctors in the world in medical research. But again, which wasn't declared, is that their institution has received hundreds of millions of dollars from drug companies that manufacture statins or new cholesterol-lowering drugs. Okay.

These are the most powerful statin promoters and some of the most powerful doctors in the world in medical research. But again, which wasn't declared, is that their institution has received hundreds of millions of dollars from drug companies that manufacture statins or new cholesterol-lowering drugs. Okay.

These are the most powerful statin promoters and some of the most powerful doctors in the world in medical research. But again, which wasn't declared, is that their institution has received hundreds of millions of dollars from drug companies that manufacture statins or new cholesterol-lowering drugs. Okay.

Yeah, absolutely right, Mark. And that reminds me actually of somebody who I cite quite regularly, Professor John Ioannidis. In Stanford, I refer to him as a Stephen Hawking in medicine. He's the most cited medical researcher in the world. He is a professor of medicine and epidemiology and statistics at Stanford. He's a mathematical genius.

Yeah, absolutely right, Mark. And that reminds me actually of somebody who I cite quite regularly, Professor John Ioannidis. In Stanford, I refer to him as a Stephen Hawking in medicine. He's the most cited medical researcher in the world. He is a professor of medicine and epidemiology and statistics at Stanford. He's a mathematical genius.